New ultrasound could spot heart trouble before It's too late for chemo patients

NCT ID NCT01212926

Completed Diagnosis Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a special heart ultrasound (2D strain imaging) can detect early signs of heart damage caused by anthracycline chemotherapy in 100 leukemia patients. The goal is to catch problems sooner, so doctors can adjust treatment and reduce the risk of permanent heart damage. Researchers measured heart function at several points over a year to see if the technique works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Echographic analysis of myocardial deformation in 2D strain (a special heart ultrasound technique)
What this could lead to: If this works, doctors could detect heart damage from chemotherapy earlier, allowing them to adjust treatment and potentially improve survival for leukemia patients.
What could go wrong: This is a small, completed study with 100 participants, so results may not apply to everyone. The technique is still experimental and not yet standard practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute leukemia Cardiotoxicity leukemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIAC TOXICITY LEUKEMIA

Contacts and locations

Locations

Service de Cardiologie et Maladies Vasculaires, Hopital du Haut Lévêque

Pessac, 33604, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.